Ophthalmic inflammatory diseases, including conjunctivitis, keratitis, uveitis, scleritis, and
related conditions, pose considerable challenges to effective management and treatment …

Ocular discomforts involve anterior/posterior-segment diseases, symptomatic distress and
associated inflammations and severe retinal disorders. Conventionally, the formulations …

Ocular disorders comprising various diseases of the anterior and posterior segments are
considered as the main reasons for blindness. Natural products have been identified as …

Allergic conjunctivitis is one of the most common external eye diseases and the prevalence
has been increasing. The mainstay of treatment is topical eye drops. However, low …

Ocular diseases can deteriorate vision to the point of blindness and thus can have a major
impact on the daily life of an individual. Conventional therapies are unable to provide …

Intrinsic shortcomings associated with conventional therapeutic strategies often compromise
treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile …

The eye consists of sensitive, compactly adjoined tissue structures which act as strong
physical (static) and physiological (dynamic) barriers that prevent entry of foreign bodies into …

Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …

Drug instillation via a topical route is preferred since it is desirable and convenient due to the
noninvasive and easy drug access to different segments of the eye for the treatment of …

Owing to the variety and complexity of ocular diseases and the natural ocular barriers, drug
therapy for ocular diseases has significant limitations, such as poor drug targeting to the site …